[HTML][HTML] The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports

M Bennett, CL Chang, M Tatley, R Savage… - ERJ Open …, 2021 - Eur Respiratory Soc
Introduction Beta-blockers are key in the management of cardiovascular diseases but
blocking airway β 2-receptors can cause severe and sometimes fatal bronchoconstriction in …

State of the art approach to managing angina and ischemia: tailoring treatment to the evidence

AJ Manolis, WE Boden, P Collins, R Dechend… - European Journal of …, 2021 - Elsevier
Stable angina represents a chronic and often debilitating condition that affects daily activities
and quality of life in patients with chronic coronary syndromes (CCS). Current European …

Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos

JL Lopez-Campos, P Almagro, JT Gómez… - Archivos de …, 2022 - Elsevier
Los modelos de atención sanitaria actuales descritos en GesEPOC indican la mejor manera
de hacer un diagnóstico correcto, la categorización de los pacientes, la adecuada selección …

[Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care

JL Lopez-Campos, P Almagro, JT Gómez… - Archivos de …, 2022 - Elsevier
The current health care models described in GesEPOC indicate the best way to make a
correct diagnosis, the categorization of patients, the appropriate selection of the therapeutic …

Role of β-blockers in the cardiovascular disease continuum: a collaborative Delphi survey-based consensus from Asia-Pacific

S Ray, T Nair, J Sawhney, Erwinanto… - Current Medical …, 2023 - Taylor & Francis
Abstract Objective This Delphi method of consensus was designed to develop scientific
statements for β-blockers in the continuum of cardiovascular diseases with a special focus …

Efficacy and Safety of Bisoprolol in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis

Z Feng, L Zhang, Y Wang, H Guo… - International Journal of …, 2023 - Taylor & Francis
Purpose To evaluate the clinical efficacy and safety of bisoprolol in patients with chronic
obstructive pulmonary disease (COPD). Research Methods This systematic review and meta …

[HTML][HTML] Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta …

NC Dos Santos, AA Camelier, AK Menezes… - Tuberculosis and …, 2024 - e-trd.org
Cardiovascular comorbidity is common in individuals with chronic obstructive pulmonary
disease (COPD). This factor interferes with pharmacological treatment. The use of β …

A relação entre o uso de betabloqueadores ea exacerbação da Doença Pulmonar Obstrutiva Crônica: uma revisão integrativa

TG Pinheiro, PSLA Junior… - Revista Eletrônica …, 2021 - acervomais.com.br
Objetivo: Discutir a relação entre o uso dos betabloqueadores e a exacerbação da Doença
Pulmonar Obstrutiva Crônica (DPOC). Métodos: Trata-se de uma Revisão Integrativa …

Selective Beta-Blockers on Chronic Obstructive Pulmonary Disease: A Literature Review

ATM Van, N Ahmad - Respiratory Science, 2024 - respiratoryscience.or.id
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) are
usually coexisting. While beta-blockers are the indispensable management of an array of …

Метаболическая активность жировой ткани у пациентов с хронической обструктивной болезнью легких в условиях хронического неспецифического …

ДВ Лапицкий, АН Ряполов, ВА Пупкевич… - 2019 - rep.bsmu.by
В статье отражены результаты изучения динамики гормонов жировой ткани лептина и
адипонектина в зависимости от выраженности неспецифического воспаления, а также …